US4350707A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Inactivation of lipid containing viruses with butylated hydroxytoluene
Assignee: Research Corp
•
Filing: 1976-02-05
•
Granted: 1982-09-21
•
Expires: 1996-02-05
Abstract
Abstract Inactivation of, and treatment of diseases caused by, lipid containing viruses, particularly herpes simplex virus, with butylated hydroxytoluene.
Inventors
- 👤 Alec D. Keith
- 👤 Wallace Snipes
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 09:41
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/045; A61K31/05; Y; Y02; Y02A; Y02A50/00; Y02A50/30
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
32 words
A method for treating a subject having a disease caused by lipid-containing viruses comprising administering to said subject an effective inactivating amount therefor of butylated hydroxytoluene in a non-toxic, pharmaceutically acceptable barrier.
Claim 2
Independent Claim
32 words
A method for treating a subject having a disease caused by lipid-containing viruses comprising administering to said subject an effective inactivating amount therefor of butylated hydroxytoluene in a non-toxic, pharmaceutically acceptable barrier.
Claim 3
Dependent Claim
20 words
A method according to claim 1, wherein the concentration of said butylated hydroxytoluene in said carrier is 1% to saturation.
Claim 4
Dependent Claim
14 words
A method according to claim 2, wherein said pharmaceutically acceptable carrier is mineral oil.
Claim 5
Dependent Claim
36 words
A method according to claim 2, wherein said pharmaceutically acceptable carrier is 40 to 60% ethanol, 30 to 45% propylene glycol, 0 to 5% water, and 0 to 8% monolaurate ethoxylated (20 units/mole) ester of sorbitan.
Claim 6
Dependent Claim
24 words
A method according to claim 2, wherein the affected area is skin, eyes and mucocutaneous areas including lips, nares, prepuce, glans penis and cervix.
Claim 7
Dependent Claim
19 words
A method according to claim 5, wherein the affected skin area is the hands, face, neck or external genitalia.
Claim 8
Dependent Claim
14 words
A method according to claim 2, wherein said virus is a herpes simplex virus.
Claim 9
Dependent Claim
25 words
A method according to claim 7, wherein said disease is an eye disease caused by herpes simplex and the butylated hydroxytoluene is applied topically thereto.
Claim 10
Dependent Claim
30 words
The method according to claim 7, wherein said disease is a topical infection caused by herpes simplex in man and the butylated hydroxytoluene is applied topically to the infected areas.
Claim 11
Independent Claim
24 words
A method for inactivating lipid-containing viruses comprising exposing said viruses to an effective inactivating amount of butylated hydroxytoluene in a non-toxic pharmaceutically acceptable carrier.
Claim 12
Independent Claim
24 words
A method for inactivating lipid-containing viruses comprising exposing said viruses to an effective inactivating amount of butylated hydroxytoluene in a non-toxic pharmaceutically acceptable carrier.
References Cited (Backward Citations)
US2081284A
Cited
FR1302984A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1985-09-20 | 1986-03-22 | 1986-09-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1989-09-20 | 1990-03-22 | 1990-09-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1993-09-20 | 1994-03-22 | 1994-09-21 | $7700.00 | Window Closed / Lapsed |